Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Adobe Acrobat profesional 6.0 o superior
Saved in:
Main Author: | Koutsky, Laura A. autor/a |
---|---|
Format: | Texto biblioteca |
Language: | eng |
Subjects: | Papilomavirus, Vacunas, Medicina preventiva, |
Online Access: | http://content.nejm.org/cgi/reprint/356/19/1915.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
by: Garland, Suzanne M., et al. -
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ a combined analysis of four randomised clinical trials
by: Ault, Kevin A. autor/a -
Vaccines for the prevention of cervical cancer
by: Stern, Peter L. editor, et al.
Published: (2010) -
Efficacy of a prophylactic adjuvanted bivalent L1 virus like particle vaccine against infection with human papillomavirus types 16 and 18 in young women an interim analysis of a phase III double blind, randomised controlled trial
by: Paavonen, Jorma, et al. -
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions a combined analysis of three randomised clinical trials
by: Joura, Elmar A., et al.